(Q40914550)

24 September 2017

title

Comparative study of the biochemical properties of proteasomes in domestic animals (English)

1 reference

24 September 2017

Mary Raule

1

1 reference

24 September 2017

Fulvia Cerruti

series ordinal

2

1 reference

24 September 2017

Paolo Cascio

series ordinal

3

1 reference

24 September 2017

publication date

30 April 2015

1 reference

Veterinary Immunology and Immunopathology

24 September 2017

published in

1 reference

24 September 2017

volume

166

1 reference

24 September 2017

issue

1-2

1 reference

24 September 2017

page(s)

43-49

1 reference

The development of proteasome inhibitors as anticancer drugs

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Purification and properties of the 26S proteasome from the rat brain: evidence for its degradation of myelin basic protein in a ubiquitin-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

PA28αβ: the enigmatic magic ring of the proteasome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Enhanced expression of interferon-gamma-induced antigen-processing machinery components in a spontaneously occurring cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Structure and functions of the 20S and 26S proteasomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Bovine spleen multicatalytic proteinase complex (proteasome). Replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1 and changes in properties and specificity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Proteasomes in immune cells: more than peptide producers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Proteasome inhibitors: from research tools to drug candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Protein degradation by the ubiquitin-proteasome pathway in normal and disease states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Immuno- and constitutive proteasomes do not differ in their abilities to degrade ubiquitinated proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Enhanced rate of degradation of basic proteins by 26S immunoproteasomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

The role of the proteasome in the generation of MHC class I ligands and immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

Altered peptidase and viral-specific T cell response in LMP2 mutant mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

The 26S proteasome: a molecular machine designed for controlled proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2015.04.005

10.1016/J.VETIMM.2015.04.005

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference